Atherosclerotic Cardiovascular Disease Risk Reduction
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease Risk Reduction.
Sign up freeTop drugs studied for this disease
-
FDA approval ·FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
FDA approves Lipfendra (enlicitide), the first oral PCSK9 inhibitor, to reduce LDL cholesterol in adults with hypercholesterolemia as an adj…